Anti-CPXM1/ CPX1/ CPXM functional antibody

Anti-CPXM1/ CPX1/ CPXM functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CPXM1/CPXM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0818-Ab-1/ GM-Tg-hg-SE0818-Ab-2Anti-Human CPXM1 monoclonal antibodyHuman
GM-Tg-rg-SE0818-Ab-1/ GM-Tg-rg-SE0818-Ab-2Anti-Rat CPXM1 monoclonal antibodyRat
GM-Tg-mg-SE0818-Ab-1/ GM-Tg-mg-SE0818-Ab-2Anti-Mouse CPXM1 monoclonal antibodyMouse
GM-Tg-cynog-SE0818-Ab-1/ GM-Tg-cynog-SE0818-Ab-2Anti-Cynomolgus/ Rhesus macaque CPXM1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0818-Ab-1/ GM-Tg-felg-SE0818-Ab-2Anti-Feline CPXM1 monoclonal antibodyFeline
GM-Tg-cang-SE0818-Ab-1/ GM-Tg-cang-SE0818-Ab-2Anti-Canine CPXM1 monoclonal antibodyCanine
GM-Tg-bovg-SE0818-Ab-1/ GM-Tg-bovg-SE0818-Ab-2Anti-Bovine CPXM1 monoclonal antibodyBovine
GM-Tg-equg-SE0818-Ab-1/ GM-Tg-equg-SE0818-Ab-2Anti-Equine CPXM1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0818-Ab-1/ GM-Tg-hg-SE0818-Ab-2; GM-Tg-rg-SE0818-Ab-1/ GM-Tg-rg-SE0818-Ab-2;
GM-Tg-mg-SE0818-Ab-1/ GM-Tg-mg-SE0818-Ab-2; GM-Tg-cynog-SE0818-Ab-1/ GM-Tg-cynog-SE0818-Ab-2;
GM-Tg-felg-SE0818-Ab-1/ GM-Tg-felg-SE0818-Ab-2; GM-Tg-cang-SE0818-Ab-1/ GM-Tg-cang-SE0818-Ab-2;
GM-Tg-bovg-SE0818-Ab-1/ GM-Tg-bovg-SE0818-Ab-2; GM-Tg-equg-SE0818-Ab-1/ GM-Tg-equg-SE0818-Ab-2
Products NameAnti-CPXM1 monoclonal antibody
Formatmab
Target NameCPXM1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CPXM1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0818-Ag-1Recombinant multi-species CPXM1/ CPX1/ CPXM protein


    Target information

    Target IDGM-SE0818
    Target NameCPXM1
    Gene ID56265,56264,296156,716790,485802,101098619,532219,100066983
    Gene Symbol and SynonymsCpx-1,CPX1,CPXM,CPXM1
    Uniprot AccessionQ96SM3
    Uniprot Entry NameCPXM1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000088882
    Target ClassificationN/A

    The target: CPXM1, gene name: CPXM1, also named as CPX1, CPXM. This gene likely encodes a member of the carboxypeptidase family of proteins. Cloning of a comparable locus in mouse indicates that the encoded protein contains a discoidin domain and a carboxypeptidase domain, but the protein appears to lack residues necessary for carboxypeptidase activity.[provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.